Kyowa Hakko Kirin, Hisamitsu To Jointly Distribute Pain Drug In Japan
Kyowa Hakko Kirin will be responsible for the approval process for the product in Japan. Under the terms of the agreement, KW-2246 will be jointly distributed by the
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.